AstraZeneca PLC (AZN)
71.20
+0.35
(+0.49%)
USD |
NASDAQ |
Apr 24, 16:00
75.53
+4.33
(+6.08%)
After-Hours: 06:22
AstraZeneca Price to Book Value: 5.640 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 5.640 |
| April 23, 2024 | 5.612 |
| April 22, 2024 | 5.555 |
| April 19, 2024 | 5.430 |
| April 18, 2024 | 5.415 |
| April 17, 2024 | 5.428 |
| April 16, 2024 | 5.407 |
| April 15, 2024 | 5.444 |
| April 12, 2024 | 5.460 |
| April 11, 2024 | 5.501 |
| April 10, 2024 | 5.395 |
| April 09, 2024 | 5.418 |
| April 08, 2024 | 5.362 |
| April 05, 2024 | 5.342 |
| April 04, 2024 | 5.334 |
| April 03, 2024 | 5.292 |
| April 02, 2024 | 5.307 |
| April 01, 2024 | 5.327 |
| March 28, 2024 | 5.366 |
| March 27, 2024 | 5.407 |
| March 26, 2024 | 5.254 |
| March 25, 2024 | 5.216 |
| March 22, 2024 | 5.248 |
| March 21, 2024 | 5.243 |
| March 20, 2024 | 5.206 |
| Date | Value |
|---|---|
| March 19, 2024 | 5.216 |
| March 18, 2024 | 5.216 |
| March 15, 2024 | 5.252 |
| March 14, 2024 | 5.31 |
| March 13, 2024 | 5.353 |
| March 12, 2024 | 5.338 |
| March 11, 2024 | 5.360 |
| March 08, 2024 | 5.267 |
| March 07, 2024 | 5.243 |
| March 06, 2024 | 5.170 |
| March 05, 2024 | 5.133 |
| March 04, 2024 | 5.132 |
| March 01, 2024 | 5.117 |
| February 29, 2024 | 5.082 |
| February 28, 2024 | 5.176 |
| February 27, 2024 | 5.254 |
| February 26, 2024 | 5.222 |
| February 23, 2024 | 5.214 |
| February 22, 2024 | 5.080 |
| February 21, 2024 | 5.156 |
| February 20, 2024 | 5.152 |
| February 16, 2024 | 5.091 |
| February 15, 2024 | 4.977 |
| February 14, 2024 | 4.884 |
| February 13, 2024 | 4.834 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.211
Minimum
Dec 10 2021
13.47
Maximum
May 13 2020
7.819
Average
6.472
Median
May 11 2023
Price to Book Value Benchmarks
| GSK PLC | 4.910 |
| Amgen Inc | 23.48 |
| Sanofi SA | 1.422 |
| Viking Therapeutics Inc | 18.77 |
| Fusion Pharmaceuticals Inc | 8.146 |
Price to Book Value Related Metrics
| PE Ratio | 37.18 |
| PS Ratio | 4.855 |
| PEG Ratio | 0.4561 |
| Price to Free Cash Flow | 33.87 |
| Price | 71.20 |
| Earnings Yield | 2.69% |
| Market Cap | 220.75B |
| PEGY Ratio | 0.445 |
| Operating PE Ratio | 25.50 |
| Normalized PE Ratio | 34.87 |